» Articles » PMID: 35138625

Ion Channels in Anesthesia

Overview
Date 2022 Feb 9
PMID 35138625
Authors
Affiliations
Soon will be listed here.
Abstract

Ion channels play a pivotal role in anesthesia, including general and regional anesthesia. Two main classes of general anesthetics (GAs) are inhalational anesthetics, such as isoflurane, sevoflurane, and nitrous oxide; injectable anesthetics, such as propofol, etomidate, and ketamine. Besides hypnotic agents, muscle relaxants for immobility and opioids for analgesia are needed to achieve balanced anesthesia. Although our understanding of anesthesia is far from complete, recent studies have revealed the molecular interactions between anesthetic drugs and ion channels, particularly, the ligand-gated ion channels (LGICs). Ionotropic GABA receptors (GABARs), the main mediators of the inhibitory signals in the central nervous system (CNS), are the key to hypnosis by general anesthetics. Ionotropic cholinergic receptors (nAChRs), expressed at the neuromuscular junction and the nervous system, are the molecular targets of muscle relaxants. GABARs and nAChRs belong to the same family of pentameric LGICs. With a completely different architecture, ionotropic glutamate receptors (iGluRs) carry the excitatory signals in the CNS and are targeted by inhalational anesthetics and ketamine. Another distinct family of ion channels, two-pore-domain K (K2P) channels, can be activated by inhalational anesthetics and cause neuron hyperpolarization. In this chapter, we will discuss the recent advance in understanding the molecular mechanisms underlying anesthesia through the molecular structures of these ion channels.

Citing Articles

Central and peripheral analgesic active components of triterpenoid saponins from and their action mechanism.

Gong J, Zhang C, Wu B, Zhang Z, Zhou Z, Zhu J Front Pharmacol. 2023; 14:1275041.

PMID: 37908974 PMC: 10613692. DOI: 10.3389/fphar.2023.1275041.


Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.

Perneel J, Rademakers R Acta Neuropathol. 2022; 144(5):807-819.

PMID: 36056242 PMC: 9547799. DOI: 10.1007/s00401-022-02486-5.

References
1.
Al-Hasani R, Bruchas M . Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011; 115(6):1363-81. PMC: 3698859. DOI: 10.1097/ALN.0b013e318238bba6. View

2.
Wickman K, Clapham D . Ion channel regulation by G proteins. Physiol Rev. 1995; 75(4):865-85. DOI: 10.1152/physrev.1995.75.4.865. View

3.
Zamponi G, Snutch T . Modulation of voltage-dependent calcium channels by G proteins. Curr Opin Neurobiol. 1998; 8(3):351-6. DOI: 10.1016/s0959-4388(98)80060-3. View

4.
Hibbs R, Gouaux E . Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature. 2011; 474(7349):54-60. PMC: 3160419. DOI: 10.1038/nature10139. View

5.
Corringer P, Poitevin F, Prevost M, Sauguet L, Delarue M, Changeux J . Structure and pharmacology of pentameric receptor channels: from bacteria to brain. Structure. 2012; 20(6):941-56. DOI: 10.1016/j.str.2012.05.003. View